Andarix Pharmaceuticals CEO to Present on Building High-Value Biotechnology Companies at Outsourcing in Clinical Trials New England Conference

Presentation Highlights Essential Tools and Strategies for Successful Biotech Company Formation

Boston, MA, United States, 17th Oct 2025 - Andarix Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation targeted radiotherapeutics for oncology, announced today that Chief Executive Officer Chris Adams will present on the essential tools and strategies needed to start a high-value biotechnology company. The presentation will take place at the 17th Annual Outsourcing in Clinical Trials New England conference.

The Outsourcing in Clinical Trials New England conference is the premier annual meeting place for clinical trial professionals from pharmaceutical, biotechnology, and medical device companies. The two-day program features four dedicated tracks covering Clinical Operations and Outsourcing, Clinical Technology and Innovation, Rare Diseases, and Patient Recruitment and Engagement. The conference brings together industry leaders, solution providers, and professionals to address the latest challenges and innovations in clinical operations and trial management.

The conference will take place October 15-16, 2025, at The Encore Hotel in Everett, Massachusetts. Conference information and registration details are available at.

About Andarix Pharmaceuticals

Andarix Pharmaceuticals is at the forefront of personalized therapies for cancer, developing both the imaging agents that can identify appropriate patients, as well as the targeted therapies for these patients. The company's products have progressed through early clinical development. The Andarix technology is based on a proprietary somatostatin peptide conjugate applicable to lung, pancreatic, neuroendocrine, and other cancers.

Extensive research has demonstrated that somatostatin receptors are highly up-regulated on several solid tumors, particularly lung, neuroendocrine, and pancreatic tumors. To learn more about Andarix, please visit www.andarix.com.

Media Contact

Organization: Andarix Pharmaceuticals

Contact Person: Chris Adams

Website: https://andarix.com

Email: Send Email

Contact Number: +16179579858

Address:1660 Soldiers Field Rd

City: Boston

State: MA

Country:United States

Release id:35543

The post Andarix Pharmaceuticals CEO to Present on Building High-Value Biotechnology Companies at Outsourcing in Clinical Trials New England Conference appeared first on King Newswire. This content is provided by a third-party source.. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section above.